Nanotechnology is the scientific branch that is concerned with understanding and applications of materials and assemblies of Nano-size (1-100 nm). This is because these materials have structural, optical, electronic, and magnetic features not found in their macromolecule counterparts.¹ Its tiny size and large surface area that increase solubility and bioavailability, and the materials biodegradability of the majority of NPs have all contributed to its great efficacy and safety as a drug delivery vehicle.²

Among the many distinct types of nanomaterials that have been employed for drug delivery, metal-based NPs have captured the interest of scientists because of their specific features (For example, high stability, adjustable shape, porosity, easy method of preparation, simple surface modification, etc.).³ Metal-based NPs are frequently used in therapeutic areas such as wound healing, cosmetic applications,⁴ cancer therapy, tissue engineering,⁵ biosensing, and bioimaging.⁶ Additionally, metal-based NPs offer improved bioavailability, controlled release, and targeted delivery.⁷

As it is for carbon, organic, and composite-based NPs, elevated human exposure to metal-based NPs has demonstrated a potential hazard to human health. After being ingested, inhaled, or coming into contact with the skin, NPs are prone to build up in sensitive organs like the heart, liver, spleen, kidney, and brain. The main mechanism causing toxicity is the enhancement of the production of reactive oxygen species.⁸

The liver is the most frequent organ exposed to NPs and the main organ for their detoxification. The large surface-to-volume ratio of NPs could make them more toxic. After penetration, they result in many pathological mechanisms in the liver such as oxidative stress, histopathological alteration, genotoxicity, and inflammation. These mechanisms disrupt the activity of a wide range of liver enzymes including antioxidant enzymes such as catalase, superoxide dismutase, glutathione S-transferase, glutathione reductase, and glutathione peroxidase, alkaline phosphatase (ALP), ALT, and AST. Along with the cytochrome enzymatic system which is the most responsible for liver detoxification ability.⁹

This review focused on the available literature studies on the effect of metal-based NPs on the aminotransferase and P450s enzymes, and thus on their potential effect on drug therapeutic response, drug-associated toxicity, and liver toxicity (Figure).

Interactions between metallic NPs and cytochrome P450
Human CYPs are a group of functional enzymes primarily expressed in the liver. There are at least 57 different cytochrome enzymes, grouped into 18 families and 43 subfamilies. CYP 450 enzymes are crucial in metabolism of drug, detoxification of xenobiotic, in addition to metabolism of endogenous molecules like steroids and fatty acids. About 80% of clinical drugs are metabolized mainly by the isoforms from the CYP1, 2, and 3 families. External factors, including food, drugs, tobacco, and alcohol, can either inhibit or induce the expression of CYPs and hence affect drug metabolism and the individual response to a drug.^10,11 As shown in Table 1, several in vivo, in vitro, and in silico studies have been carried out to investigate the effect of different metallic NPs on P450s enzymes activity.

Table (1):
Metallic NPs effects on CYP activity in in vivo, in vitro, and in silico

Copper NPs
Huaqiao and colleagues carried out an in vivo study using male Sprague-Dawley rats fed orally with copper NPs (Cu-NPs) for seven days. Cu-NPs (80 nm) in 400 mg/kg daily dose significantly inhibit the expression of the mRNA and the activity of the liver enzymes CYP 2C11, 2E1, 1A2,2D6, and 3A1. However, CYP 2E1 and 3A1 mRNA levels were increased by 100 mg/kg dose of nano-copper.¹² The same research group also demonstrated significant inhibition in the level of rats renal activity and mRNA of CP450 enzymes by oral Cu-NPs (80 nm, 200 mg/kg). This effect on CYP450 was associated with the inhibition of nuclear receptors and induction of STAT3/5, Akt, p70S6K, CREB, P38, ERK1/2, and NF-kB signaling pathways. Based on this finding, they believe that by the induction of oxidative stress and inflammatory response in rat kidneys, Cu-NPs can induce TAT, MAPK, and NF-kB Band therefore inhibit CYP450 enzymes.¹³ The same results were obtained when the research group continued their work to investigate the Cu-NPs effect on CYP 450 in rat brain. Reduction in most of CYP450 enzyme expression in response to high Cu-NPs dosages (80 nm, 200 mg/kg).¹⁴ Oral administration of 200 mg/kg/day Cu-NPs to male Sprague–Dawley rats resulted in down regulation of hepatic gene expression, protein, and activity for CYP450 1A2, 3A2, 2C11, 2E1, and 2D6. The signaling pathways of NF-B, MAPK, and STAT5 were found to be involved in the molecular mechanisms causing these effects.¹⁵

Silver NPs
The in vitro effect of silver nanoparticle (Ag-NPs) 12.4 nm on human CYP450 was examined by Warisnoicharoen and colleagues. Dose-dependent Inhibition of the CYP450 enzymes activity was observed. CYP3A4 isoform showed the greatest inhibition with 13.52 µM IC50 value followed by CYP2C19, CYP2C9, and CYP1A2 with 14.31 µM, 26.46 µM, and 43.51 µM IC50 values, respectively.¹⁶ In a prospective, single-blind controlled study, two weeks of oral administration of a commercial colloidal Ag-NPs product to human volunteers result in a detectable silver in human serum. However, this silver did not produce any significant changes in CYP 450 1A2, 2C9, 2C19, 3A4, and 2E1.¹⁷ Nootcharin and colleagues consider the molecular docking and QM calculations to understand the mechanism of deep interaction between Ag-NPs and CYP 450 enzymes specific inhibitor-binding pocket. Among the investigated isoforms (CYP1A2, CYP3A4, CYP2E1, CYP2D6, CYP2C9, and CYP2C19), CYP2D6, CYP2C9, and CYP2C19key amino acidsVal370y, Leu362, and Ile362, respectively, were found to strongly interact with Ag₃ clusters at a distance of 3Å.¹⁸ After 12 days of exposure to 8 and 10 ppm of Ag-NPs (35 nm) extract from the shell of Cocos nucifera in the second and third instars, respectively, the level of P450s in Aedes aegypti considerably increased.¹⁹ Sharp and significant down regulation in the cyp3a11 and cyp2c29 genes expression was observed through real-time polymerase chain reaction for liver biopsies from BALB/C mice subjected to 2 mg/kg/day of intraperitoneal (IP)Ag-NPs (15–35 nm) for 21 days.²⁰

Gold NPs
An in vitro study conducted by Meiling and colleagues research group showed that tannic acid-stabilized gold nanoparticles (Au-NPs) could irreversibly suppress the enzymes CYP3A4, CYP2D6, CYP2C9, CYP2C19, and to a lesser extent, CYP1A2 in a time, size, and concentration-dependent manner. It was also demonstrated that the level of inhibition is determined by the ratio of microsomal protein (the source of CYP450 enzymes)/NP. However, due to the possibility of metabolite and/or probe substrate adsorption to NPs, the observed metabolite production in the in vitro model may not accurately reflect the activity of the enzyme.²¹ In male rats, the liver enzymes CYP1A1, CYP2E1, and CYP2D6 were found to be significantly inhibited by a low oral dose of Au-NPs 15 nm (4 mg/Kg) for 10 days.²² Intravenous (IV) administration of polyethyleneimine modified Au-NPs(6.4 nm) to mice in 11.5 and 23µg for 1 and 7 days, respectively, led to enhancement of hepatic gene expression of the enzymes Cyp: 2a4, 2c37, 2c50, 2d10, 2d34, 2d40, while no significant alteration in the genes of Cyp: 1a2, 2c40, 2c44, 2d26, 2e1, and 3a11was observed.²³ Shuang group studied the effect of Au-NPs coated with either citric acid (CA), polyethyleneglycol (PEG), or chitosan (CS) on the expression of P450s after IV administration of 60-120 µg/mouse for 1 day and 1 week. In this study, mice exposed to a high dose (120 µg/mouse) of CA-coated NPs for 24 hours exhibited elevation of the Cyp: 2a4,2c37, 2c50, 2d10, 2d34, and 2d40 isoforms by 2.5, 13.3, 17.9, 36.0, 14.2, and 33.7 fold, respectively. Then the levels increased dramatically after 7 days of exposure. Similarly, PEG-coated NPs was found to induce these isoforms in mice. However, the levels of these isoforms were neither increased nor decreased in mice treated with chitosan-coated NPs.²⁴ Cyp3a11 and cyp2c29 genes were dramatically inhibited in mice exposed to 2 mg/kg/day of IPAu-NPs (10 nm)for 21 days.²⁰

Titanium dioxide NPs
Pan and colleagues examined Titanium dioxide nanoparticles (TiO2-NPs) effect on CYP2E1 in fraction of rat liver using four concentrations (0.5, 1, 5, and 10 ppm). Measurement of formaldehyde using Nash’s reagent indicated no change in CYP2E1 activity when compared with the control.²⁵ Another study reported the impact of three concentrations of TiO2-NPs (zero, 200, and 800 µg/ml) on CYP 450 gene expression in vitex agnus-castus L. Real-time PCR demonstrated an increase in CYP 450 gene expression by 800 µg/ml concentration.²⁶ In an in vivo study using Wistar male albino rats fed orally with TiO2-NPs (≤ 100 nm) 600 mg/kg for five days demonstrated a significant decline in CYP 2E1 level.²⁷

Silicon NPs
Three different forms of porous silicon nanoparticles (PSi-NPs), including aminopropylsilane-modified Psi, alkyne-terminated thermally hydrocarbonized Psi, and thermally carbonized PSi, were developed and examined against CYP isoforms in human liver microsomes. The study’s findings showed that these PSi-NPs considerably decreased the activity of (CYP1A2, CYP2A6, CYP2D6, and CYP3A4) isoforms.²⁸ The levels of Cyp19a1 and Cyp17a1 genes were significantly inhibited in testes of Wistar albino Male Rats treated orally with 1, 10, and 100 mg/kg body weight/day Silica oxide (SiO2-NPs) 10-30 nm for 22 days. The purpose of this study was to examine the effect of SiO2NPs on the reproductive performance of rats as the testes Cyp19a1 and Cyp17a1 genes are responsible for steroid hormones synthesis and testosterone construction.²⁹

Manganese oxides NPs
Sustained Manganese oxide nanoparticles (Mn₃O₄-NPs) exposure was found to be responsible for the elevation of CYP1A2. IP administration of 20 mg/Kg/Week/ 2 or 4 months of Mn3O4- NPs 15 nm into the rats indicated upregulation of CYP1A2 gene after 4 months of treatment as indicated by transcription profile analysis and upregulation of CYP1A2 enzyme as indicated by immunohistochemistry assay.³⁰

Zinc NPs
Zinc oxide nanoparticles (ZnO-NPs) 30 nm demonstrated dose-dependent manner stimulation of CYP450 in spleen tissue of male Wistar rat treated with either 50 or 250 mg/kg/week IP for 4 weeks.³¹ Oral administration of ZnO-NPs to mice at a 25 mg/kg daily dose for 12 weeks resulted in over expression of CYP450 in mice’s liver.³² Lactating Wistar rats treated orally with ZnO-NPs 25 nm (50 mg/kg/day) for 19 days exhibited significant inhibition of P450s reductase in rats in their offspring liver tissue.³³

Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) enzymes are two of the liver biochemical tests that are most frequently requested in both inpatient and outpatient settings. ALT is mainly found in hepatocytes (with lesser amount in cardiac, renal, and muscular tissue) and is therefore unique to hepatic injury. It promotes the synthesis of pyruvate and glutamate in the liver which are crucial for production of energy. For males, the normal ALT level is 29-33 IU/L, while for females, it is 19-25 IU/L. Similar to ALT, AST can also be found in the liver but it is more abundant than ALT in heart, brain, renal tissue, and skeletal muscles. AST promotes the metabolism of amino acids and its normal level is < 35 IU/L. In liver diseases, the hepatocytes release the aminotransferase resulting in the elevation of their serum levels.³⁴ Metallic NPs have been evaluated on their ability to induce aminotransferase enzymes by employing various in vivo studies (Table 2).

Table (2):
Metallic NPs effects on aminotransferases activities in vivo

Copper NPs
In an in vivo study, IV administration of half the determined lethal dose (225 mg/kg) of copper oxide nanoparticles (CuO-NPs) (60 to 100 nm) daily for 4 days to albino mice significantly elevated the level of ALT up to 105.67 U/L and AST level up to 306.00 U/L.³⁵ Another study was conducted by Arafaa and colleagues to assess the role of quercetin in reducing the CuO-NPs-induced liver toxicity in female rats. IP administration of CuO-NPs (>20 nm) in doses of 3 mg/kg or 50 mg/kg for one week increased the level of AST and ALT by 16.15, 30.03, or 20.77, 61.42 folds, respectively.³⁶ Interestingly, no significant elevation in aminotransferases activities in vivo enzymes levels was observed in BALB/c mice after administration of the greenly synthesized Cu-NPs (17 and 41 nm) at 1, 2, and 5 mg/kg/day oral doses for two weeks.³⁷ A study similar to Arafaa and colleagues’ study was performed by Yousef and colleagues to evaluate the protective activity of Crocin, the main active principle in saffron, against CuO-NPs-induced hepatotoxicity in rats. In this study, the elevation aminotransferases activities in vivo liver enzymes along with other biomarkers were used as indicators for CuO-NPs-induced rat intoxication.³⁸

Silver NPs
In an in vivo assay employing Male Wistar rats treated topically with Ag-NPs gel (1% m/v, nano-particles size of 10-30 nm) four times a day/28 days, to evaluate their activity to heal a thermally induced burn wound in rat dorsum, no significant change was shown in the level of aminotransferases activities in vivo enzymes in rats blood.³⁹ Feeding of Sprague–Dawley rats with 500 mg/d/kg BW Ag-NPs (20 nm) along with the standard diet for 81 days led to a 12% increase in plasma ALT enzyme level.⁴⁰ To evaluate Ag-NPs effect of on the aquatic environment, Imani and colleagues employed rainbow trout (Oncorhynchus mykiss) hematological parameters following exposure to 0.1, 0.2, or 0.4 mg/l Ag-NPs solution. After 8 days of treatment, aminotransferases enzymes were significantly elevated with the 0.4 mg/l group experiencing the largest elevations of up to 42.2 and 502.5 for aminotransferases, respectively.⁴¹ Acute IP dosing (2,000 mg/kg) of Ag-NPs (20–60 nm) followed by another dose after two days to albino rats resulted in a considerable elevation of aminotransferases to 54.4, and 105 U/L, respectively.⁴² Acute toxicity of oral Ag-NPs was investigated by Patlolla and colleagues through the administration of high doses(50 or 100 mg/kg/d) of Ag-NPs (10 nm) to Sprague-Dawley rats over a short period of 5 days. According to optical density values, this resulted in significant elevation (< 0.05) of aminotransferases.⁴³ Heydrnejad and colleagues reported that oral administration of Ag-NPs 40 nm (20 or 50 ppm/d/2wks) significantly elevated aminotransferases levels in the serum of both male and female BALB/c mice.⁴⁴ Swiss albino mice treated to IP 26, 52, or 78 mg/kg of Ag-NPs 43.60 nm for 3 days had significantly elevated aminotransferases levels in their serum, with ALT levels being the highest.⁴⁵ However, no significant alteration was shown in aminotransferases serum levels in male Sprague-Dawley rats orally exposed to 30, 125, 300, or 700 mg/kg Ag-NPs for 28 days.⁴⁶ In their study, Peng and colleagues compared the effects of the free uncoated Ag-NPs to those coated with low molecular weight chitosan (LMWC) or polyvinylpyrrolidone (PVP) on the liver toxicity indices aminotransferases. The LMWC-Ag-NPs, followed by the PVP-Ag-NPs demonstrated the most considerable lower levels of aminotransferases, while uncoated NPs displayed the highest values.⁴⁷ Aminotransferases concentrations in male Wistar rat serum demonstrated a considerable increase following 25 mg/kg of IP Ag-NPs for two weeks.⁴⁸ A comparative examination of the effects of the feeding of Ag and Au-NPs on adult zebrafish was conducted by Ramachandran and colleagues. They reported that zebrafish exposed to half the determined lethal concentration of Ag-NPs (12.25 µg/L) for 14 days expressed higher liver tissue aminotransferases than those exposed to half the determined lethal concentration of Au-NPs (20.5 mg/L).⁴⁹ Another study showed that C. gariepinus treated with 100 g/L Ag-NPs for 15 days resulted in a considerable rise in blood enzyme activity of aminotransferases.⁵⁰

Gold NPs
Conflicting results were obtained for serum aminotransferases levels after the IV administration of Au-NPs 25 nm(0.3619 mg/ml/kg) to male Wistar rats for 3 days. While AST increased by up to 24%, ALT decreased by 43%.⁵¹ Another study examined the effects of IV administration of 1 mg/kg/day/3 days of two Au-NPs types—solid Au-NPs (SGNPs) and porous Au-NPs (PGNPs)—on aminotransferases in male rabbits. These two Au-NPs types are 35 nm and 28 nm, respectively. The only result that has been seen is an elevation in AST serum level following PGNPs.⁵² Patlolla and colleagues compared the effect of poly-ethylene-glycol-coated and free Au-NPs on Sprague Dawley rats serum aminotransferases after oral administration of four different doses for five days. A dose-dependent increase of both enzymes was observed and PEG-coated NPs demonstrated a greater extent of induction than uncoated NPs.⁵³ As for the IP route, administration of 5 µg/2.85 ׳ 10¹¹ Au-NPs 10 nm daily for one week considerably elevated the Wistar male rats serum levels of aminotransferases.⁵⁴

Titanium dioxide NPs
Serum aminotransferases in mice exposed to different doses (324-2592 mg/kg) of IP TiO2-NPs 100 nm significantly increased after 14 days of administration.⁵⁵ In another study, male Sprague-Dawley rats injected with different doses (30, 50, 70 mg/kg) and sizes (10-15 nm) TiO2 IP every other day for 3 weeks displayed a significant elevation in serum ALT (P< 0.001), while AST didn’t show considerable change.⁵⁶ Orazizadeh and colleagues investigated the hepatoprotective effect of glycyrrhizic acid in male Wistar rats, the liver was intoxicated by gavage administration of 300 mg/kg of TiO2 (50-100 nm) for two weeks. Serum aminotransferases significantly elevated as compared to control untreated rats.⁵⁷ In a similar investigation carried out by Hassaneina and colleagues’ research group to examine thymoquinone ability to protect against TiO2-NPs induced liver toxicity, male rats were intoxicated by a one-time oral dose (300 mg/kg) of TiO2-NPs. This led to a dramatic elevation of serum aminotransferases (P ≤ 0.001).⁵⁸ TiO2-NPs 28.8 nm have been examined on their ability to induce aminotransferases in Clariasgariepinus. All concentrations used (1-10 mg/L) of TiO2-NPs were able to elevate the levels of aminotransferases in fish serum at all exposure periods (1, 4, and 7 days). The higher the concentration of TiO2-NPs the more pronounced the elevation of the levels of the enzymes.⁵⁹

Silica NPs
Several diameters of silica nanoparticles (Si-NPs) (70, 300, and 1000 nm) were used by Nishimori and colleagues to assess the impact of NPs size on hepatotoxicity. The 300 and 1000 nm NPs were found to be safe even at higher doses, whereas mice injected IV with 30 mg/kg of 70 nm NPs had severe liver damage and an increase in aminotransferase serum level in a dose-dependent manner.⁶⁰ Using smaller Si-NPs (30, 50, and 70 nm), the same research group carried out the same study. With the 30 nm size having the most impact, liver damage and an increase in aminotransferases were reported at all sizes in a dose-dependent manner.⁶¹ Acute liver toxicity of IP Si-NPs 50 nm was examined by administration of 0.25 mg/kg single dose to Male Tuck-Ordinary mice. Significant elevation of aminotransferases levels was observed with p-values of 0.01 and 0.005, respectively.⁶² In contrast, after 14 days of treatment with various single doses of Si-NPs of 150 nm(1,2.5,5,10,100,200, and 300 mg/kg), no significant elevation of serum aminotransferases levels was seen in male Balb/C mice.⁶³ Further investigation employed the freshwater fish, Oreochromis mossambicus, the liver tissue aminotransferases expression declined after being exposed to 12 mg/L of SiO2-NPs for one month of.⁶⁴

Zinc NPs
Pasupuleti and colleagues obtained surprising results after administration of different single oral doses of 5-2000 mg/kg ZnO-NPs20 nm to Sprague Dawley rats. Two weeks after treatment, aminotransferases levels have declined in a dose dependent manner.⁶⁵ The freshwater snail Biomphalaria alexandrina was employed by Fahmy and colleagues to assess the ZnO-NPs impacts on aquatic ecosystems. The treated snails soft tissue and hemolymph aminotransferases levels increased after three weeks of exposure to sublethal quantities of LC10 (7µg/ml) and LC25 (35µg/ml).⁶⁶ To test Hesperidin’s ability to protect against ZnO-NPs (< 100 nm) hepatotoxicity, male Wistar rats were administered a single 600 mg/kg of ZnO-NPs through IP. The serum activities of aminotransferases increased noticeably in the group that only received ZnO-NPs.⁶⁷ When compared to rats that received comparable doses of Zn-NPs, those received ZnO-NPs showed a greater elevation in blood aminotransferases.⁶⁸ In another study conducted to investigate the potentially hazardous effects of ZnO-NP ≤ 100 nm on aquaculture, it was demonstrated that exposure to ZnO-NP (50 mg/L) for 30 days significantly increased serum aminotransferases of Nile tilapia.⁶⁹ A significant positive association was found between the doses of ZnO NPs (20 to 40 nm)fed to female Swiss albino rats and aminotransferases serum values after 28 days of daily administration.⁷⁰ Another experiment was carried out to examine the ability of the natural active compound, Silymarin, to protect against ZnO-NPs-induced hepatotoxicity in albino rats. Rats that were orally intoxicated using ZnO-NPs (50 mg/kg) for 4 weeks demonstrated a remarkable rise in aminotransferases serum levels. ALT increased up to 240 U/L while AST reached the maximum of 360 U/L.⁷¹

Iron NPs
The IV injection of 10 mg Oleic acid-Pluronic-coated iron oxide (Fe3O4) MNPs to Male Sprague–Dawley rats caused a transient increase in aminotransferases serum levels after 24 hours of administration.⁷² The serum and liver aminotransferases levels were significantly increased in female Wistar rats following treatment with 1,000, and 2,000mg/kg oral dose of Fe3O4-NPs 30 nm. However, kidney aminotransferases levels were down regulated.⁷³ BALB/c mice exposed to 150 and 300 g/gr dosages of Fe3O4-NPs (20-30 nm) by oral gavage had considerably higher levels of aminotransferases in their serum, while no significant elevations were observed with the lower doses.⁷⁴ After 1,7,14, and 28 days of receiving a single dose of 10 mg/kg of dextran-coatedFe3O4-NPs via IV injection, no appreciable modulations were found in Wistar rats serum aminotransferases levels.⁷⁵ Shakra and colleagues evidenced that coating of Fe3O4-NPs with either bare or PEG didn’t protect against hepatotoxicity and remarkable elevation of aminotransferases resulted after administration of 15 and 30 mg/kg dose via oral gavage to male albino rats daily for one month. The elevation was more pronounced with bare-coated NPs.⁷⁶ Oral administration of 200 mg/kg single dose Fe3O4-NPs (30 nm) to male Wistar rats resulted in significant upregulation of blood ALT.⁷⁷ Moreover, Fe3O4-NPs was found to upregulate aminotransferases expression serum levels of carp fry after being exposed to 0.15 mg/l of Fe₃O₄-NPs.⁷⁸

Cerium NPs
Cerium oxide nanoparticles (CeO2-NPs) 10 nm have not been found to produce any change in aminotransferases serum levels of female Wistar rats injected IP with 200 mg/kg three times weekly for thirteen weeks.⁷⁹ CeO2-NPs demonstrated hepatoprotective activity against diethylnitrosamine-induced livertoxicity. Pretreatment of male BALB/c mice with CeO2-NPs (<10 nm) IP at 100 and 200µg/kg daily for eight consecutive days decreased ALT activity by 24% and 23%, respectively.⁸⁰

Magnesium NPs
In vivo study on male Wistar rats injected with Magnesium Oxide nanoparticles (MgO-NPs) 10-15 nm IP revealed a considerable increase in AST but not ALT at 250 and 500 µg/ml doses every other day for 28 days. But no significant change was observed at lower doses.⁸¹ As for orally administered MgO-NPs, male Sprague Dawley rats fed with 40 mg/kg MgO-NPs daily for one month did not demonstrate any remarkable alteration in serum levels of aminotransferases.⁸²

Selenium NPs
Oral administration of a high dose (0.1 mg/g) of k-carrageenan coated selenium NPs to Wistar rats protects against tetrachloride-induced liver damage and normalizes the serum levels of aminotransferases after one week of administration. On the other hand, administration of the same dose to healthy rats increased the level of AST.⁸³

Aluminium NPs
The serum levels of aminotransferases were elevated in albino rats treated with LC90 of aluminum oxide NPs.⁸⁴

Molybdenum NPs
IP administration of molybdenum NPs at (1 and 25 mg/kg) and molybdenum oxide NPs at (1.2 and 29 mg/kg) increased the Wistar rat’s serum level of aminotransferase after 1, 7, 14, days of administration.⁸⁵